0001801885-20-000002.txt : 20200623 0001801885-20-000002.hdr.sgml : 20200623 20200623135102 ACCESSION NUMBER: 0001801885-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 EFFECTIVENESS DATE: 20200623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oisin Biotechnologies, Inc. CENTRAL INDEX KEY: 0001801885 IRS NUMBER: 465167496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369506 FILM NUMBER: 20981468 BUSINESS ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001801885 Oisin Biotechnologies, Inc. 800 5TH AVENUE, SUITE 4100 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE None None Corporation true Matthew Scholz 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Gary Hudson 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director David Gobel 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Director Eric Garcia 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Steve Hilbert 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer John Lewis 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Other Decline to Disclose 06b false 2020-06-10 false true false 0 5000000 2118936 2881064 false 27 0 0 0 false Oisin Biotechnologies, Inc. Matthew Scholz Matthew Scholz President 2020-06-22